Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest stories Story 24 Feb 2025 COMING SOON: Hypothesize This! – a new science podcast from UCB Read More Story 11 Feb 2025 UCBCares® - a decade of support and beyond Read More Story 10 Feb 2025 Driving innovation forward: UCB unveils new R&D facility Read More Latest press releases The press releases are intended for media and financial analysts Press release 12 Feb 2025 BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in... Read More Press release 31 Jan 2025 RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two... Read More Press release 15 Jan 2025 UCB showcases decade of growth and Patient Value Strategy driving differentiated innovation Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 12 Feb 2025 BIMZELX[®]▼(bimekizumab) two-year data at EHSF 2025 demonstrate sustained disease control in... Read More
Press release 31 Jan 2025 RYSTIGGO[®]▼(rozanolixizumab), for generalized myasthenia gravis (gMG), receives EU approval for two... Read More
Press release 15 Jan 2025 UCB showcases decade of growth and Patient Value Strategy driving differentiated innovation Read More
